Reach Us +44-1235-425476
Synthetic Opioids, (re)Emerging Problem in Europe and North America | OMICS International | Abstract
ISSN: 1522-4821

International Journal of Emergency Mental Health and Human Resilience
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Short Communication

Synthetic Opioids, (re)Emerging Problem in Europe and North America

Magdalena Sustkova*

Department of Pharmacology, Third Faculty of Medicine, Charles University, Czech Republic

*Corresponding Author:
E-mail: [email protected]


I would like to draw the reader´s attention to group of synthetic opioids, which have been increasingly appearing or re-emerging during the last few years on the black drug markets in many European countries, the USA, Canada and elsewhere. Newly encouraged interest in synthetic opioids has been observed for last 6-7 years and recently has grown intensively. Increasing number of European countries (Germany, Bulgaria, Slovakia, Czech Republic etc.) have reported abuse of fentanyl (Janssen, 1962), which so far has been rather limited to Estonia (Fentanyl in Europe, 2012; Mounteney, 2015), fentanylrelated intoxications and deaths have markedly increased recently (to hundreds) in the USA (NIDA, 2015) and Canada (CCNDU Bulletin, 2014). Also the spectrum of different structures of synthetic opioids on the black market has significantly risen and many of these substances are already associated with serious or fatal overdoses (EMCDDA, 2009-12; European Drug Report, 2013-15).